Ubs Group Ag Opko Health, Inc. Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Opko Health, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 666,116 shares of OPK stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

666,116

Previous 1,036,650 35.74%

Holding current value

$1.01 Million

Previous $1.24 Million 33.07%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.21 - $1.42 $448,346 - $526,158	-370,534 Reduced 35.74%	666,116 $832,000
Q1 2024 May 13, 2024	SELL	$0.87 - $1.57 $327,685 - $591,340	-376,650 Reduced 26.65%	1,036,650 $1.24 Million
Q4 2023 Feb 09, 2024	BUY	$1.23 - $1.63 $491,126 - $650,842	399,290 Added 39.38%	1,413,300 $2.13 Million
Q3 2023 Nov 09, 2023	BUY	$1.5 - $2.17 $845,319 - $1.22 Million	563,546 Added 125.1%	1,014,010 $1.62 Million
Q2 2023 Aug 11, 2023	BUY	$1.37 - $2.17 $192,202 - $304,437	140,294 Added 45.23%	450,464 $977,000
Q1 2023 May 12, 2023	BUY	$1.06 - $1.61 $91,160 - $138,460	86,000 Added 38.36%	310,170 $452,000
Q4 2022 Feb 08, 2023	BUY	$1.05 - $2.01 $5,913 - $11,320	5,632 Added 2.58%	224,170 $280,000
Q3 2022 Nov 10, 2022	BUY	$1.81 - $2.81 $85,158 - $132,207	47,049 Added 27.44%	218,538 $413,000
Q2 2022 Aug 10, 2022	SELL	$2.33 - $3.61 $1.65 Million - $2.56 Million	-707,897 Reduced 80.5%	171,489 $434,000
Q1 2022 May 16, 2022	BUY	$2.87 - $4.93 $453,273 - $778,619	157,935 Added 21.89%	879,386 $3.03 Million
Q4 2021 Feb 14, 2022	SELL	$3.52 - $5.15 $337,307 - $493,503	-95,826 Reduced 11.73%	721,451 $3.47 Million
Q3 2021 Nov 15, 2021	BUY	$3.44 - $4.24 $106,461 - $131,219	30,948 Added 3.94%	817,277 $2.98 Million
Q2 2021 Aug 13, 2021	SELL	$3.33 - $4.55 $2.4 Million - $3.28 Million	-721,691 Reduced 47.86%	786,329 $3.18 Million
Q1 2021 May 12, 2021	BUY	$4.19 - $5.99 $3.32 Million - $4.75 Million	793,262 Added 110.98%	1,508,020 $6.47 Million
Q4 2020 Feb 11, 2021	SELL	$3.27 - $4.87 $6.15 Million - $9.17 Million	-1,882,052 Reduced 72.48%	714,758 $2.82 Million
Q3 2020 Nov 12, 2020	BUY	$2.99 - $5.96 $6.52 Million - $13 Million	2,180,531 Added 523.81%	2,596,810 $9.58 Million
Q2 2020 Jul 31, 2020	SELL	$1.15 - $3.41 $423,371 - $1.26 Million	-368,149 Reduced 46.93%	416,279 $1.42 Million
Q1 2020 May 01, 2020	SELL	$1.34 - $2.32 $947,192 - $1.64 Million	-706,860 Reduced 47.4%	784,428 $1.05 Million
Q4 2019 Feb 14, 2020	BUY	$1.42 - $2.17 $343,003 - $524,167	241,552 Added 19.33%	1,491,288 $2.19 Million
Q3 2019 Nov 14, 2019	BUY	$1.75 - $2.47 $894,321 - $1.26 Million	511,041 Added 69.18%	1,249,736 $2.61 Million
Q2 2019 Aug 14, 2019	SELL	$1.79 - $2.61 $1.09 Million - $1.59 Million	-608,010 Reduced 45.15%	738,695 $1.8 Million
Q1 2019 May 14, 2019	SELL	$2.42 - $3.83 $8,276 - $13,098	-3,420 Reduced 0.25%	1,346,705 $3.52 Million
Q4 2018 Feb 14, 2019	BUY	$2.46 - $3.87 $1.95 Million - $3.07 Million	794,513 Added 143.0%	1,350,125 $4.06 Million
Q3 2018 Nov 14, 2018	BUY	$3.29 - $6.29 $163,424 - $312,443	49,673 Added 9.82%	555,612 $1.92 Million
Q2 2018 Aug 14, 2018	SELL	$2.99 - $4.99 $4.29 Million - $7.17 Million	-1,435,999 Reduced 73.95%	505,939 $2.38 Million
Q1 2018 May 15, 2018	BUY	$3.11 - $5.12 $697,859 - $1.15 Million	224,392 Added 13.06%	1,941,938 $6.16 Million
Q4 2017 Feb 14, 2018	SELL	$4.61 - $7.04 $5.46 Million - $8.34 Million	-1,184,016 Reduced 40.81%	1,717,546 $8.42 Million
Q3 2017 Nov 14, 2017	BUY	$5.88 - $7.11 $9.83 Million - $11.9 Million	1,672,275 Added 136.04%	2,901,562 $19.9 Million
Q2 2017 Aug 14, 2017	BUY	N/A	451,063 Added 57.96%	1,229,287 $8.09 Million
Q1 2017 Nov 14, 2017	BUY	N/A	778,224	778,224 $6.23 Million

Others Institutions Holding OPK

# of Institutions

253

Shares Held

183M

Call Options Held

4.23M

Put Options Held

8.83M

View Full List

About OPKO HEALTH, INC.

Ticker OPK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 771,960,000
Market Cap $1.17B
Description
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...

More about OPK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account